Average Co-Inventor Count = 4.67
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genfit (14 from 67 patents)
2. Enyo Pharma (7 patents)
14 patents:
1. 11103484 - Methods of treatment for cholestatic and fibrotic diseases
2. 10905680 - Methods of treatment for cholestatic and fibrotic diseases
3. 10722575 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
4. 10350181 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
5. 10130612 - Methods of treatment for cholestatic and fibrotic diseases
6. 10130613 - Methods of treatment for cholestatic and fibrotic diseases
7. 10117855 - Methods of treatment for cholestatic and fibrotic diseases
8. 10117856 - Methods of treatment for cholestatic and fibrotic diseases
9. 10022343 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
10. 9782373 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
11. 9585853 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
12. 9221751 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
13. 8895619 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
14. 8772342 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders